Latest Pharmaxis Inc. Stories
EXTON, Pa., Feb.
A Potential New Tool in the Diagnosis and Assessment of Asthma EXTON, Pa., March 3 /PRNewswire/ -- Pharmaxis, Inc., a wholly owned subsidiary of Pharmaxis Ltd (ASX: PXS, Nasdaq: PXSL), an emerging respiratory specialty pharmaceutical company, announced today that it has filed a New Drug Application (NDA), electronically, with the U.S.
- To befool; deceive; balk; jilt.
- An illusion; a trick; a cheat.